Synopsis of recent research by authors named "Tsai-Lan Liao"
Tsai-Lan Liao's recent research focuses on developing therapeutic strategies for various types of cancer, particularly emphasizing the efficacy of novel compounds and combination therapies in enhancing existing treatments.
Notable studies include the exploration of magnolol's effects on oral squamous cell carcinoma and the investigation of quetiapine's potential to improve radiotherapy outcomes for hepatocellular carcinoma.
Additionally, Liao has contributed to research on the synergistic use of regorafenib and 18β-glycyrrhetinic acid, as well as the application of immunotherapy in glioblastoma, showcasing a commitment to addressing treatment resistance and improving patient outcomes.
